| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.006 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |